{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:26:42Z","timestamp":1783056402802,"version":"3.54.6"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Coagulation Research Fund 245 of Karolinska Institutet"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","award":["DNR 2-5132\/218"],"award-info":[{"award-number":["DNR 2-5132\/218"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Region Stockholm"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Predicting survival accurately in patients with advanced cancer is important in guiding interventions and planning future care. Objective tools are therefore needed. Blood biomarkers are appealing due to their rapid measurement and objective nature. Thrombosis is a common complication in cancer. Recent data indicate that tumor-induced neutrophil extracellular traps (NETs) are pro-thrombotic. We therefore performed a comprehensive investigation of circulating markers of neutrophil activation, NET formation, coagulation and fibrinolysis in 106 patients with terminal cancer. We found that neutrophil activation and NET markers were prognostic in terminal cancer patients. Interestingly, markers of coagulation and fibrinolysis did not have a prognostic value in this patient group, and there were weak or no correlations between these markers and markers of neutrophil activation and NETs. This suggest that NETs are linked to a poor prognosis through pathways independent of coagulation. Additional studies are needed to determine the utility of circulating neutrophil activation and NET markers, alone or in concert with established clinical parameters, as objective and reliable prognostic tools in advanced cancer.<\/jats:p>","DOI":"10.1038\/s41598-021-84476-3","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T11:02:36Z","timestamp":1614769356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Axel","family":"Rosell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Schmedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Wall\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Th\u00e5lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"84476_CR1","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00520-019-04727-y","volume":"27","author":"D Hui","year":"2019","unstructured":"Hui, D. et al. Prognostication in advanced cancer: update and directions for future research. Support Care Cancer 27, 1973\u20131984. https:\/\/doi.org\/10.1007\/s00520-019-04727-y (2019).","journal-title":"Support Care Cancer"},{"key":"84476_CR2","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1200\/jco.2006.10.5411","volume":"25","author":"S Gripp","year":"2007","unstructured":"Gripp, S. et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J. Clin. Oncol. 25, 3313\u20133320. https:\/\/doi.org\/10.1200\/jco.2006.10.5411 (2007).","journal-title":"J. Clin. Oncol."},{"key":"84476_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","volume":"327","author":"P Glare","year":"2003","unstructured":"Glare, P. A systematic review of physicians\u2019 survival predictions in terminally ill cancer patients. BMJ 327, 195\u2013190. https:\/\/doi.org\/10.1136\/bmj.327.7408.195 (2003).","journal-title":"BMJ"},{"key":"84476_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/s0885-3924(98)00146-8","volume":"17","author":"M Maltoni","year":"1999","unstructured":"Maltoni, M. et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. J. Pain Symptom Manag. 17, 240\u2013247. https:\/\/doi.org\/10.1016\/s0885-3924(98)00146-8 (1999).","journal-title":"J. Pain Symptom Manag."},{"key":"84476_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s005200050242","volume":"7","author":"T Morita","year":"1999","unstructured":"Morita, T., Tsunoda, J., Inoue, S. & Chihara, S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 7, 128\u2013133 (1999).","journal-title":"Support Care Cancer"},{"key":"84476_CR6","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","volume":"89","author":"LM Forrest","year":"2003","unstructured":"Forrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J. & Dunlop, D. J. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br. J. Cancer 89, 1028\u20131030. https:\/\/doi.org\/10.1038\/sj.bjc.6601242 (2003).","journal-title":"Br. J. Cancer"},{"key":"84476_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","author":"AJ Templeton","year":"2014","unstructured":"Templeton, A. J. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. JNCI J. Natl. Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju124 (2014).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"84476_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-0-387-79962-9_3","volume-title":"Coagulation in Cancer","author":"FR Rickles","year":"2009","unstructured":"Rickles, F. R. & Falanga, A. Coagulation in Cancer 31\u201341 (Springer, Boston, 2009)."},{"key":"84476_CR9","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","volume":"49","author":"AJ Walker","year":"2013","unstructured":"Walker, A. J., Card, T. R., West, J., Crooks, C. & Grainge, M. J. Incidence of venous thromboembolism in patients with cancer\u2014a cohort study using linked United Kingdom databases. Eur. J. Cancer 49, 1404\u20131413. https:\/\/doi.org\/10.1016\/j.ejca.2012.10.021 (2013).","journal-title":"Eur. J. Cancer"},{"key":"84476_CR10","doi-asserted-by":"publisher","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","volume":"9","author":"F Horsted","year":"2012","unstructured":"Horsted, F., West, J. & Grainge, M. J. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 9, e1001275. https:\/\/doi.org\/10.1371\/journal.pmed.1001275 (2012).","journal-title":"PLoS Med."},{"key":"84476_CR11","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/s2352-3026(18)30063-2","volume":"5","author":"I Pabinger","year":"2018","unstructured":"Pabinger, I. et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol. 5, e289\u2013e298. https:\/\/doi.org\/10.1016\/s2352-3026(18)30063-2 (2018).","journal-title":"Lancet Haematol."},{"key":"84476_CR12","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","volume":"112","author":"C Ay","year":"2008","unstructured":"Ay, C. et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112, 2703\u20132708. https:\/\/doi.org\/10.1182\/blood-2008-02-142422 (2008).","journal-title":"Blood"},{"key":"84476_CR13","first-page":"1153","volume":"34","author":"P Ferroni","year":"2014","unstructured":"Ferroni, P. et al. Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer\u2014relationship with clinical outcome. Anticancer Res. 34, 1153\u20131161 (2014).","journal-title":"Anticancer Res."},{"key":"84476_CR14","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","volume":"97","author":"C Ay","year":"2012","unstructured":"Ay, C. et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica 97, 1158\u20131164. https:\/\/doi.org\/10.3324\/haematol.2011.054718 (2012).","journal-title":"Haematologica"},{"key":"84476_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/raon-2016-0024","volume":"51","author":"NF Dovnik","year":"2017","unstructured":"Dovnik, N. F. & Takac, I. Prognostic significance of uPA\/PAI-1 level, HER2 status, and traditional histologic factors for survival in node-negative breast cancer patients. Radiol. Oncol. 51, 65\u201373. https:\/\/doi.org\/10.1515\/raon-2016-0024 (2017).","journal-title":"Radiol. Oncol."},{"key":"84476_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.thromres.2009.02.014","volume":"124","author":"R Palmirotta","year":"2009","unstructured":"Palmirotta, R. et al. Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer. Thromb. Res. 124, 403\u2013408. https:\/\/doi.org\/10.1016\/j.thromres.2009.02.014 (2009).","journal-title":"Thromb. Res."},{"key":"84476_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ijc.20189","volume":"111","author":"P Ferroni","year":"2004","unstructured":"Ferroni, P. et al. Prognostic value of soluble P-selectin levels in colorectal cancer. Int. J. Cancer 111, 404\u2013408. https:\/\/doi.org\/10.1002\/ijc.20189 (2004).","journal-title":"Int. J. Cancer"},{"key":"84476_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-1320-5","author":"C Zhang","year":"2018","unstructured":"Zhang, C., Jia, Y., Jia, Y., Zhang, X. & Li, K. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer. Int. J. Clin. Oncol. https:\/\/doi.org\/10.1007\/s10147-018-1320-5 (2018).","journal-title":"Int. J. Clin. Oncol."},{"key":"84476_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jjco\/hye075","volume":"31","author":"M Oya","year":"2001","unstructured":"Oya, M., Akiyama, Y., Okuyama, T. & Ishikawa, H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn. J. Clin. Oncol. 31, 388\u2013394. https:\/\/doi.org\/10.1093\/jjco\/hye075 (2001).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"84476_CR20","doi-asserted-by":"publisher","first-page":"51551","DOI":"10.18632\/oncotarget.17936","volume":"8","author":"L Xu","year":"2017","unstructured":"Xu, L. et al. A high plasma D-dimer level predicts poor prognosis in gynecological tumors in East Asia area: a systematic review and meta-analysis. Oncotarget 8, 51551\u201351558. https:\/\/doi.org\/10.18632\/oncotarget.17936 (2017).","journal-title":"Oncotarget"},{"key":"84476_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2018.03.001","volume":"165","author":"Y Hisada","year":"2018","unstructured":"Hisada, Y., Thalin, C., Lundstrom, S., Wallen, H. & Mackman, N. Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients. Thromb. Res. 165, 1\u20135. https:\/\/doi.org\/10.1016\/j.thromres.2018.03.001 (2018).","journal-title":"Thromb. Res."},{"key":"84476_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","volume":"5","author":"MET Tesselaar","year":"2007","unstructured":"Tesselaar, M. E. T. et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J. Thromb. Haemost. JTH 5, 520\u2013527. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02369.x (2007).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"84476_CR23","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1538-7836.2012.04754.x","volume":"10","author":"J Thaler","year":"2012","unstructured":"Thaler, J. et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J. Thromb. Haemost. JTH 10, 1363\u20131370. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04754.x (2012).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"84476_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1182\/blood-2015-01-624023","volume":"126","author":"J Etulain","year":"2015","unstructured":"Etulain, J. et al. P-selectin promotes neutrophil extracellular trap formation in mice. Blood 126, 242\u2013246. https:\/\/doi.org\/10.1182\/blood-2015-01-624023 (2015).","journal-title":"Blood"},{"key":"84476_CR25","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1158\/1078-0432.CCR-15-2463","volume":"22","author":"C Alfaro","year":"2016","unstructured":"Alfaro, C. et al. Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs). Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 22, 3924\u20133936. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2463 (2016).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"84476_CR26","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1073\/pnas.1200419109","volume":"109","author":"M Demers","year":"2012","unstructured":"Demers, M. et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc. Natl. Acad. Sci. USA 109, 13076\u201313081. https:\/\/doi.org\/10.1073\/pnas.1200419109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"84476_CR27","doi-asserted-by":"publisher","first-page":"e0191231","DOI":"10.1371\/journal.pone.0191231","volume":"13","author":"C Thalin","year":"2018","unstructured":"Thalin, C. et al. Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer. PLoS ONE 13, e0191231. https:\/\/doi.org\/10.1371\/journal.pone.0191231 (2018).","journal-title":"PLoS ONE"},{"key":"84476_CR28","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1158\/1078-0432.ccr-13-3203","volume":"20","author":"MF Sanmamed","year":"2014","unstructured":"Sanmamed, M. F. et al. Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 20, 5697\u20135707. https:\/\/doi.org\/10.1158\/1078-0432.ccr-13-3203 (2014).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"84476_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jth.13218","volume":"14","author":"EM Reitter","year":"2016","unstructured":"Reitter, E. M. et al. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment. J. Thromb. Haemost. JTH 14, 294\u2013305. https:\/\/doi.org\/10.1111\/jth.13218 (2016).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"84476_CR30","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/cncr.21485","volume":"104","author":"M Di Nisio","year":"2005","unstructured":"Di Nisio, M., Niers, T. M., Reitsma, P. H. & Buller, H. R. Plasma cytokine and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular weight heparin administration. Cancer 104, 2275\u20132281. https:\/\/doi.org\/10.1002\/cncr.21485 (2005).","journal-title":"Cancer"},{"key":"84476_CR31","first-page":"337","volume":"63","author":"JA Foekens","year":"2003","unstructured":"Foekens, J. A. et al. The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Cancer Res. 63, 337\u2013341 (2003).","journal-title":"Cancer Res."},{"key":"84476_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15906","author":"E Grilz","year":"2019","unstructured":"Grilz, E. et al. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer. Br. J. Haematol. https:\/\/doi.org\/10.1111\/bjh.15906 (2019).","journal-title":"Br. J. Haematol."},{"key":"84476_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.119.312463","author":"C Thalin","year":"2019","unstructured":"Thalin, C., Hisada, Y., Lundstrom, S., Mackman, N. & Wallen, H. Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis. Arterioscler Thromb. Vasc. Biol. https:\/\/doi.org\/10.1161\/atvbaha.119.312463 (2019).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"84476_CR34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-743211","author":"Y Hisada","year":"2017","unstructured":"Hisada, Y. & Mackman, N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood https:\/\/doi.org\/10.1182\/blood-2017-03-743211 (2017).","journal-title":"Blood"},{"key":"84476_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15003","author":"C Th\u00e5lin","year":"2020","unstructured":"Th\u00e5lin, C. et al. Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma. J. Thromb. Haemost. JTH https:\/\/doi.org\/10.1111\/jth.15003 (2020).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"84476_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/rth2.12165","volume":"3","author":"Y Hisada","year":"2019","unstructured":"Hisada, Y. & Mackman, N. Measurement of tissue factor activity in extracellular vesicles from human plasma samples. Res. Pract. Thromb. Haemost. 3, 44\u201348. https:\/\/doi.org\/10.1002\/rth2.12165 (2019).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"84476_CR37","doi-asserted-by":"publisher","first-page":"e0154484","DOI":"10.1371\/journal.pone.0154484","volume":"11","author":"S Arelaki","year":"2016","unstructured":"Arelaki, S. et al. Gradient infiltration of neutrophil extracellular traps in colon cancer and evidence for their involvement in tumour growth. PLoS ONE 11, e0154484. https:\/\/doi.org\/10.1371\/journal.pone.0154484 (2016).","journal-title":"PLoS ONE"},{"key":"84476_CR38","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1172\/JCI67484","volume":"123","author":"J Cools-Lartigue","year":"2013","unstructured":"Cools-Lartigue, J. et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Investig. 123, 3446\u20133458. https:\/\/doi.org\/10.1172\/JCI67484 (2013).","journal-title":"J. Clin. Investig."},{"key":"84476_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1711","author":"J Park","year":"2016","unstructured":"Park, J. et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aag1711 (2016).","journal-title":"Sci. Transl. Med."},{"key":"84476_CR40","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/ijc.30635","volume":"140","author":"S Najmeh","year":"2017","unstructured":"Najmeh, S. et al. Neutrophil Extracellular Traps sequester circulating tumor cells via beta1-integrin mediated interactions. Int. J. Cancer 140, 2321\u20132330. https:\/\/doi.org\/10.1002\/ijc.30635 (2017).","journal-title":"Int. J. Cancer"},{"key":"84476_CR41","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862. https:\/\/doi.org\/10.1084\/jem.20100239 (2010).","journal-title":"J. Exp. Med."},{"key":"84476_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fimmu.2012.00307","volume":"3","author":"M Leshner","year":"2012","unstructured":"Leshner, M. et al. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Frontiers Immunol. 3, 307. https:\/\/doi.org\/10.3389\/fimmu.2012.00307 (2012).","journal-title":"Frontiers Immunol."},{"key":"84476_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1083\/jcb.200806072","volume":"184","author":"Y Wang","year":"2009","unstructured":"Wang, Y. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184, 205\u2013213. https:\/\/doi.org\/10.1083\/jcb.200806072 (2009).","journal-title":"J. Cell Biol."},{"key":"84476_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"SR Clark","year":"2007","unstructured":"Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463\u2013469. https:\/\/doi.org\/10.1038\/nm1565 (2007).","journal-title":"Nat. Med."},{"key":"84476_CR45","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. USA 107, 15880\u201315885. https:\/\/doi.org\/10.1073\/pnas.1005743107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"84476_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mc.20169","volume":"45","author":"X Chang","year":"2006","unstructured":"Chang, X. & Han, J. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol. Carcinog. 45, 183\u2013196. https:\/\/doi.org\/10.1002\/mc.20169 (2006).","journal-title":"Mol. Carcinog."},{"key":"84476_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archinte.1991.00400020085018","volume":"151","author":"MK Cruickshank","year":"1991","unstructured":"Cruickshank, M. K., Levine, M. N., Hirsh, J., Roberts, R. & Siguenza, M. A standard heparin nomogram for the management of heparin therapy. Arch. Intern. Med. 151, 333\u2013337 (1991).","journal-title":"Arch. Intern. Med."},{"key":"84476_CR48","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1158\/1078-0432.CCR-0348-03","volume":"10","author":"M Roselli","year":"2004","unstructured":"Roselli, M. et al. Soluble CD40 ligand plasma levels in lung cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 10, 610\u2013614 (2004).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"84476_CR49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.thromres.2006.11.002","volume":"120","author":"V Dymicka-Piekarska","year":"2007","unstructured":"Dymicka-Piekarska, V., Matowicka-Karna, J., Gryko, M., Kemona-Chetnik, I. & Kemona, H. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer. Thromb Res. 120, 585\u2013590. https:\/\/doi.org\/10.1016\/j.thromres.2006.11.002 (2007).","journal-title":"Thromb Res."},{"key":"84476_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5114\/pm.2018.74897","volume":"17","author":"DB Majchrzak-Baczmanska","year":"2018","unstructured":"Majchrzak-Baczmanska, D. B., Glowacka, E., Wilczynski, M. & Malinowski, A. Serum concentrations of soluble (s)L- and (s)P-selectins in women with ovarian cancer. Prz Menopauzalny 17, 11\u201317. https:\/\/doi.org\/10.5114\/pm.2018.74897 (2018).","journal-title":"Prz Menopauzalny"},{"key":"84476_CR51","doi-asserted-by":"publisher","first-page":"7157","DOI":"10.1158\/1078-0432.Ccr-04-0812","volume":"10","author":"IH Benoy","year":"2004","unstructured":"Benoy, I. H. et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 10, 7157\u20137162. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-04-0812 (2004).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"84476_CR52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.17219\/acem\/62120","volume":"26","author":"Y Ma","year":"2017","unstructured":"Ma, Y. et al. IL-6, IL-8 and TNF-alpha levels correlate with disease stage in breast cancer patients. Adv. Clin. Exp. Med. Off. Organ. Wroclaw Med. Univ. 26, 421\u2013426. https:\/\/doi.org\/10.17219\/acem\/62120 (2017).","journal-title":"Adv. Clin. Exp. Med. Off. Organ. Wroclaw Med. Univ."},{"key":"84476_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2172-14-36","volume":"14","author":"N Vaguliene","year":"2013","unstructured":"Vaguliene, N., Zemaitis, M., Lavinskiene, S., Miliauskas, S. & Sakalauskas, R. Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol. 14, 36. https:\/\/doi.org\/10.1186\/1471-2172-14-36 (2013).","journal-title":"BMC Immunol."},{"key":"84476_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1378\/chest.103.1.196","volume":"103","author":"EC Gabazza","year":"1993","unstructured":"Gabazza, E. C. et al. Evaluating prethrombotic state in lung cancer using molecular markers. Chest 103, 196\u2013200 (1993).","journal-title":"Chest"},{"key":"84476_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/030089169808400310","volume":"84","author":"O Ozyilkan","year":"1998","unstructured":"Ozyilkan, O. et al. Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer. Tumori 84, 364\u2013367 (1998).","journal-title":"Tumori"},{"key":"84476_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00001721-200201000-00001","volume":"13","author":"M Kohli","year":"2002","unstructured":"Kohli, M., Fink, L. M., Spencer, H. J. & Zent, C. S. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb. 13, 1\u20135 (2002).","journal-title":"Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb."},{"key":"84476_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.thromres.2016.03.002","volume":"141","author":"C Claussen","year":"2016","unstructured":"Claussen, C. et al. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer. Thromb. Res. 141, 39\u201348. https:\/\/doi.org\/10.1016\/j.thromres.2016.03.002 (2016).","journal-title":"Thromb. Res."},{"key":"84476_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0049-3848(01)00404-2","volume":"105","author":"N Iversen","year":"2002","unstructured":"Iversen, N., Lindahl, A. K. & Abildgaard, U. Elevated plasma levels of the factor Xa-TFPI complex in cancer patients. Thromb. Res. 105, 33\u201336 (2002).","journal-title":"Thromb. Res."},{"key":"84476_CR59","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3892\/br.2018.1151","volume":"9","author":"H Dai","year":"2018","unstructured":"Dai, H. et al. D-dimer as a potential clinical marker for predicting metastasis and progression in cancer. Biomed. Rep. 9, 453\u2013457. https:\/\/doi.org\/10.3892\/br.2018.1151 (2018).","journal-title":"Biomed. Rep."},{"key":"84476_CR60","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1186\/1471-2407-14-991","volume":"14","author":"M Chaari","year":"2014","unstructured":"Chaari, M. et al. Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability. BMC Cancer 14, 991. https:\/\/doi.org\/10.1186\/1471-2407-14-991 (2014).","journal-title":"BMC Cancer"},{"key":"84476_CR61","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/gyno.1999.5610","volume":"75","author":"CH Ho","year":"1999","unstructured":"Ho, C. H., Yuan, C. C. & Liu, S. M. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in ovarian cancer. Gynecol. Oncol. 75, 397\u2013400. https:\/\/doi.org\/10.1006\/gyno.1999.5610 (1999).","journal-title":"Gynecol. Oncol."},{"key":"84476_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","volume":"116","author":"RD Dolan","year":"2017","unstructured":"Dolan, R. D., McSorley, S. T., Horgan, P. G., Laird, B. & McMillan, D. C. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit. Rev. Oncol. Hematol. 116, 134\u2013146. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.06.002 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"84476_CR63","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Bruhl","year":"2012","unstructured":"von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819\u2013835. https:\/\/doi.org\/10.1084\/jem.20112322 (2012).","journal-title":"J. Exp. Med."},{"key":"84476_CR64","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","volume":"36","author":"DA Stakos","year":"2015","unstructured":"Stakos, D. A. et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur. Heart J. 36, 1405\u20131414. https:\/\/doi.org\/10.1093\/eurheartj\/ehv007 (2015).","journal-title":"Eur. Heart J."},{"key":"84476_CR65","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1038\/s41598-018-22156-5","volume":"8","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice. Sci. Rep. 8, 4020. https:\/\/doi.org\/10.1038\/s41598-018-22156-5 (2018).","journal-title":"Sci. Rep."},{"key":"84476_CR66","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2016-06-722298","volume":"129","author":"DF Noubouossie","year":"2017","unstructured":"Noubouossie, D. F. et al. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood 129, 1021\u20131029. https:\/\/doi.org\/10.1182\/blood-2016-06-722298 (2017).","journal-title":"Blood"},{"key":"84476_CR67","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.aam8897","volume":"358","author":"M Jimenez-Alcazar","year":"2017","unstructured":"Jimenez-Alcazar, M. et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science (New York, NY) 358, 1202\u20131206. https:\/\/doi.org\/10.1126\/science.aam8897 (2017).","journal-title":"Science (New York, NY)"},{"key":"84476_CR68","doi-asserted-by":"publisher","first-page":"e1320009","DOI":"10.1080\/2162402x.2017.1320009","volume":"6","author":"J Cedervall","year":"2017","unstructured":"Cedervall, J. et al. Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice. Oncoimmunology 6, e1320009. https:\/\/doi.org\/10.1080\/2162402x.2017.1320009 (2017).","journal-title":"Oncoimmunology"},{"key":"84476_CR69","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-15-3051","volume":"76","author":"J Cedervall","year":"2016","unstructured":"Cedervall, J., Zhang, Y. & Olsson, A. K. Tumor-induced NETosis as a risk factor for metastasis and organ failure. Cancer Res. 76, 4311\u20134315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3051 (2016).","journal-title":"Cancer Res."},{"key":"84476_CR70","doi-asserted-by":"publisher","first-page":"232470961453928","DOI":"10.1177\/2324709614539283","volume":"2","author":"C Thalin","year":"2014","unstructured":"Thalin, C. et al. Trousseau\u2019s syndrome, a previously unrecognized condition in acute ischemic stroke associated with myocardial injury. J. Investig. Med. High Impact Case Rep. 2, 2324709614539283. https:\/\/doi.org\/10.1177\/2324709614539283 (2014).","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"84476_CR71","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.thromres.2016.01.009","volume":"139","author":"C Thalin","year":"2016","unstructured":"Thalin, C. et al. NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation. Thromb. Res. 139, 56\u201364. https:\/\/doi.org\/10.1016\/j.thromres.2016.01.009 (2016).","journal-title":"Thromb. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84476-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84476-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84476-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:35:22Z","timestamp":1670042122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84476-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84476"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84476-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"3 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5074"}}